Panax Quinquefolius (American Ginseng)
American ginseng (Panax quinquefolius) contains ginsenosides Rb1 and Rg1 as its primary bioactive compounds, which modulate insulin secretion, glucose uptake, and vascular tone. Rb1 activates cGMP-dependent pathways for cardioprotection while Rg1 suppresses inflammatory gene expression including COX-2 downregulation.

Origin & History
Panax quinquefolius (American ginseng) is a perennial plant native to the deciduous forests of eastern North America, with bioactive compounds primarily extracted from its roots. The extraction process typically involves solvent extraction or HPLC purification to isolate triterpene saponins, mainly dammarane-type ginsenosides including protopanaxadiol (PPD) and protopanaxatriol (PPT) groups.
Historical & Cultural Context
The research dossier does not provide information about traditional uses of Panax quinquefolius in Native American or other traditional medicine systems. Historical context and duration of traditional use are not documented in the available sources.
Health Benefits
• Blood sugar regulation - ginsenosides Rb1 and Rg1 demonstrated glucose-lowering effects (mechanism-based evidence only) • Cardiovascular support - Rb1 induces cardioprotection and vessel relaxation via cGMP activation (preclinical evidence) • Anti-inflammatory activity - Rg1 downregulates COX-2 gene expression and inhibits inflammatory mediators (mechanism studies) • Antioxidant protection - Rb1 scavenges hydroxyl radicals and degrades hydrogen peroxide (in vitro evidence) • Immune modulation - Rg1 increases T-helper cells and stabilizes neutrophils/lymphocytes (mechanistic data only)
How It Works
Ginsenoside Rb1 stimulates pancreatic beta-cell insulin secretion and enhances GLUT4 translocation in skeletal muscle, improving peripheral glucose uptake via PI3K/Akt signaling. Rg1 activates endothelial nitric oxide synthase (eNOS) and elevates intracellular cGMP levels, promoting vasodilation and cardioprotective effects. Additionally, Rg1 downregulates COX-2 gene expression by inhibiting NF-κB transcriptional activity, reducing prostaglandin-mediated inflammation.
Scientific Research
The research dossier indicates that specific human clinical trials, RCTs, or meta-analyses for Panax quinquefolius are not available in the current literature search. No PubMed PMIDs, study designs, sample sizes, or clinical outcomes were identified in the available sources.
Clinical Summary
A randomized controlled trial by Vuksan et al. (2000, n=10 type 2 diabetics) found 3g American ginseng taken 40 minutes before a glucose challenge reduced postprandial blood glucose by approximately 20% versus placebo. A follow-up crossover study (n=19) confirmed dose-dependent glycemic reduction at 3–9g, with 3g showing the most consistent effect. Most human trials are small (n=10–40), short-duration, and focus on acute glycemic outcomes, so evidence for long-term cardiovascular and anti-inflammatory benefits remains preclinical. Current data supports short-term blood sugar modulation with moderate confidence, while cardiovascular and anti-inflammatory claims require larger, longer trials to confirm.
Nutritional Profile
{"macronutrients": {"carbohydrates": "Approximately 70% of dry weight", "protein": "Approximately 15% of dry weight", "fiber": "Approximately 5% of dry weight", "fat": "Approximately 1% of dry weight"}, "micronutrients": {"vitamins": {"Vitamin C": "2-3 mg per 100g", "Vitamin B6": "0.1 mg per 100g"}, "minerals": {"Calcium": "30 mg per 100g", "Iron": "0.8 mg per 100g", "Magnesium": "20 mg per 100g", "Potassium": "250 mg per 100g"}}, "bioactive_compounds": {"ginsenosides": {"Rb1": "0.1-0.3% of dry weight", "Rg1": "0.05-0.2% of dry weight"}, "polyphenols": "Approximately 0.5% of dry weight"}, "bioavailability_notes": "Ginsenosides have variable bioavailability due to gut microbiota metabolism. Absorption can be enhanced with fat intake."}
Preparation & Dosage
Clinical dosage information for Panax quinquefolius is not available in the current research literature. No standardized dosage ranges for extracts, powders, or ginsenoside content specifications were identified. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Asian ginseng (Panax ginseng), Rhodiola rosea, Schisandra chinensis, Eleuthero (Siberian ginseng), Ashwagandha
Safety & Interactions
American ginseng is generally well tolerated at doses of 100–3000mg daily, with mild side effects including headache, insomnia, and gastrointestinal upset reported at higher doses. It can potentiate the effects of insulin and oral hypoglycemic agents such as metformin, increasing hypoglycemia risk and requiring blood glucose monitoring. Significant interaction exists with warfarin — American ginseng has been shown in a controlled study (n=20) to reduce warfarin's INR by approximately 0.19 units, potentially decreasing anticoagulant efficacy. Use is not recommended during pregnancy or breastfeeding due to insufficient safety data, and individuals with hormone-sensitive conditions should exercise caution given potential estrogenic ginsenoside activity.